Work

Abstract PD10-08: Interim safety in the inavolisib + ribociclib or abemaciclib + fulvestrant or letrozole arms of MORPHEUS-pan breast cancer: A Phase 1b/2 study of efficacy and safety of multiple treatment combinations in patients with advanced breast cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-pd10-08

Authors: E. Gal-Yam, Y. Park, A. Sonnenblick, S. Breuer, R. Yerushalmi, S. Loi, K. Lee, H. Martin, J. Soong, K. Kallapur, R. Schwab, C. Cahuzac, T. Fisher, J. Sohn

Institutions: Sheba Medical Center, Samsung Medical Center, Tel Aviv Sourasky Medical Center, Shaare Zedek Medical Center, Bikur Cholim Hospital, Tel Aviv University, Rabin Medical Center, The University of Melbourne, Peter MacCallum Cancer Centre, National Cancer Center, National Cancer Center Hospital, Fiona Stanley Hospital, Roche (United Kingdom), Genentech, Roche (Switzerland), Yonsei University

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129399249

Cites:

Cited by:

Related to: